Novo Nordisk A/S:

* U.S. FEDERAL TRADE COMMISSION SAYS IT HAS CONCERNS ABOUT

NOVO

NORDISK BID FOR METSERA - FTC LETTER TO METSERA

* FTC IS CONCERNED ABOUT NOVO-METSERA DEAL PROCEEDING

WITHOUT

FILING FOR HART-SCOTT-RODINO ANTITRUST CLEARANCE

* FTC SAYS IT HAS NO POSITION ON WHETHER THE PROPOSED

NOVO-METSERA

TRANSACTION ABIDES BY ANTITRUST LAW

* US SAYS STRUCTURE OF NOVO NORDISK TRANSACTION MAY REDUCE

METSERA'S INCENTIVE TO CONTINUE BRINGING DRUGS TO MARKET